The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Resection, biopsy, and survival in malignant glial neoplasms: A retrospective study of clinical parameters, therapy, and outcome
Abstract
✓ Between July, 1984, and October, 1988, 263 patients (163 male, 100 female), aged from 4 to 83 years (mean 52 years), with malignant brain gliomas underwent surgical procedures: stereotactic biopsy in 160 and resection in 103 patients. There were 170 grade IV astrocytomas, 17 grade IV mixed oligoastrocytomas, 44 grade III astrocytomas, 22 grade III mixed oligoastrocytomas, and 10 malignant oligodendrogliomas. Overall median survival time was 30.1 weeks for grade IV gliomas, 87.7 weeks for grade III gliomas, and 171.3 weeks for malignant oligodendrogliomas. Multivariate analysis in 218 newly diagnosed cases revealed that the variables most strongly correlated with survival time were: tumor grade, patient age, seizures as a first symptom, a Karnofsky Performance Scale score of less than 70%, tumor resection, and a radiation therapy dose greater than 50 Gy. The proportions of patients receiving tumor resection versus biopsy in each of these prognosis factor groups were similar. Since most of the 22 patients with midline and brain-stem tumors were treated with biopsy alone, these were excluded. Considering 196 newly diagnosed patients with cortical and subcortical tumors, grade IV glioma patients undergoing resection of the contrast-enhancing mass (as evidenced on computerized tomography and magnetic resonance imaging) and postoperative external beam radiation therapy lived longer than those undergoing biopsy only and radiation therapy (median survival time 50.6 weeks and 33.0 weeks, respectively; Smirnov test, p = 0.0380). However, survival in patients with resected grade III gliomas was no better than in those with biopsied grade III lesions (p = 0.746). The authors conclude that, in selected grade IV gliomas, resection of the contrast-enhancing mass followed by radiation therapy is associated with longer survival times than radiation therapy after biopsy alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
Pathology of Tumours of the Nervous System
(1990) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199001000-00011 · Cited by 3,472
Walker, M. D., Green, S. B., Byar, D. P., Alexander, E., Batzdorf, U., Brooks, W. H., Hunt, W. E., MacCarty, C. S., Mahaley, M. S., Mealey, J., et al. (1980) · New England Journal of Medicine · doi:10.1056/nejm198012043032303 · Cited by 1,611
Grading of astrocytomas: A simple and reproducible method
Daumas-Duport, C., Scheithauer, B., O'Fallon, J., & Kelly, P. (1988) · Cancer · doi:10.1002/1097-0142(19881115)62:10<2152::aid-cncr2820621015>3.0.co;2-t · Cited by 891
Self-citationGlioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications
Burger, P. C., Vogel, F. S., Green, S. B., & Strike, T. A. (1985) · Cancer · doi:10.1002/1097-0142(19850901)56:5<1106::aid-cncr2820560525>3.0.co;2-2 · Cited by 651
Chang, C. H., Horton, J., Schoenfeld, D., Salazer, O., Perez-Tamayo, R., Kramer, S., Weinstein, A., Nelson, J. S., & Tsukada, Y. (1983) · Cancer · doi:10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2 · Cited by 598
Ammirati, M., Vick, N., Youlian, L., Ivan, C., & Mikhael, M. (1987) · Neurosurgery · doi:10.1227/00006123-198708000-00012 · Cited by 467
THE FORMS OF GROWTH IN GLIOMAS AND THEIR PRACTICAL SIGNIFICANCE
SCHERER, H. J. (1940) · Brain · doi:10.1093/brain/63.1.1 · Cited by 408
KELLY, P. J., DAUMAS-DUPORT, C., SCHEITHAUER, B. W., KALL, B. A., & KISPERT, D. B. (1987) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65470-6 · Cited by 403
Self-citationBurger, P. C., Dubois, P. J., Schold, S. C., Smith, K. R., Odom, G. L., Crafts, D. C., & Giangaspero, F. (1983) · Journal of Neurosurgery · doi:10.3171/jns.1983.58.2.0159 · Cited by 397
A SIMPLIFIED CLASSIFICATION OF THE GLIOMAS
Kernohan, J. W., Mabon, R. F., Svien, H. J., & Adson, A. W. (1949) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)26182-1 · Cited by 360
Radiation therapy for neoplasms of the brain
Leibel, S. A., & Sheline, G. E. (1987) · Journal of Neurosurgery · doi:10.3171/jns.1987.66.1.0001 · Cited by 357
Pathology of Tumours of the Nervous System
Timperley, W. (1989) · Journal of Clinical Pathology · doi:10.1136/jcp.42.12.1314-d · Cited by 356
Winger, M. J., Macdonald, D. R., & Cairncross, J. G. (1989) · Journal of neurosurgery · doi:10.3171/jns.1989.71.4.0487 · Cited by 310
Nazzaro, J. M., & Neuwelt, E. A. (1990) · Journal of Neurosurgery · doi:10.3171/jns.1990.73.3.0331 · Cited by 299
Wood, J. R., Green, S. B., & Shapiro, W. R. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.2.338 · Cited by 274
Modified Kolmogorov-Smirnov Test Procedures with Application to Arbitrarily Right-Censored Data
Fleming, T. R., O'Fallon, J. R., O'Brien, P. C., & Harrington, D. P. (1980) · Biometrics · doi:10.2307/2556114 · Cited by 237
Self-citationThe Treatment of Glioblastoma Multiforme of the Brain
Jelsma, R., & Bucy, P. C. (1967) · Journal of Neurosurgery · doi:10.3171/jns.1967.27.5.0388 · Cited by 233
Smith, M. T., Ludwig, C. L., Godfrey, A. D., & Armbrustmacher, V. W. (1983) · Cancer · doi:10.1002/1097-0142(19831201)52:11<2107::aid-cncr2820521123>3.0.co;2-x · Cited by 177
Correlates of survival and the Daumas-Duport grading system for astrocytomas
Kim, T. S., Halliday, A. L., Hedley‐Whyte, E. T., et al. (1991) · Journal of neurosurgery · doi:10.3171/jns.1991.74.1.0027 · Cited by 157
Triethylene Melamine in the Treatment of Neoplastic Disease
Rundles, R. W., & BARTON, W. B. (1952) · Blood · doi:10.1182/blood.v7.5.483.483 · Cited by 143
Postoperative Irradiation of Glioblastomas: Results in a Randomized Series
Andersen, A. P. (1978) · Acta Radiologica Oncology Radiation Physics Biology · doi:10.3109/02841867809128178 · Cited by 134
Survival after stereotactic biopsy of malignant gliomas
Coffey, R. J., Lunsford, L. D., & Taylor, F. H. (1988) · Neurosurgery · doi:10.1097/00006123-198803000-00003 · Cited by 124
Ten-year survival among patients with supratentorial astrocytomas grade III and IV
Salford, L. G., Brun, A. E., & Nirfalk, S. (1988) · Journal of neurosurgery · doi:10.3171/jns.1988.69.4.0506 · Cited by 108
Long Term Survival among Patients with Malignant Brain Tumors
LIEBERMAN, A. N., Foo, S. H., Ransohoff, J., Wise, A., GEORGE, A. E., Gordon, W., & Walker, R. (1982) · Neurosurgery · doi:10.1227/00006123-198204000-00006 · Cited by 77
Computerized tomography in the prognosis of malignant cerebral gliomas
Murovic, J. A., Turowski, K., Wilson, C. B., Hoshino, T., & Levin, V. A. (1986) · Journal of neurosurgery · doi:10.3171/jns.1986.65.6.0799 · Cited by 42
Cited by
Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment
Giese, A., Bjerkvig, R., Berens, M. E., & Westphal, M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.063 · Cited by 1,200
Brown, T. J., Brennan, M. C., Li, M., Church, E. W., Brandmeir, N. J., Rakszawski, K. L., Patel, A. S., Rizk, E. B., Suki, D., Sawaya, R., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.1373 · Cited by 1,081
Functional Outcome after Language Mapping for Glioma Resection
Sanai, N., Mirzadeh, Z., & Berger, M. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067819 · Cited by 1,065
Long-term survival with glioblastoma multiforme
Krex, D., Klink, B., Hartmann, C., von Deimling, A., Pietsch, T., Simon, M., Sabel, M., Steinbach, J. P., Heese, O., Reifenberger, G., et al. (2007) · Brain · doi:10.1093/brain/awm204 · Cited by 887
Stummer, W., Novotny, A., Stepp, H., Goetz, C., Bise, K., & Reulen, H. J. (2000) · Journal of Neurosurgery · doi:10.3171/jns.2000.93.6.1003 · Cited by 881
Metadata
- Authors
- Devaux, B. C., O'Fallon, J. R., & Kelly, P. J.
- Venue
- Journal of Neurosurgery
- Published
- 1993-05
- Volume
- 78
- Issue
- 5
- Pages
- 767-775
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W1996899549
- Cited by
- 358
- References
- 28
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.